Growth Metrics

Idexx Laboratories (IDXX) Long-Term Deferred Tax (2016 - 2018)

Idexx Laboratories has reported Long-Term Deferred Tax over the past 3 years, most recently at $9.8 million for Q1 2018.

  • For Q1 2018, Long-Term Deferred Tax rose 67.43% year-over-year to $9.8 million; the TTM value through Mar 2018 reached $9.8 million, up 67.43%, while the annual FY2017 figure was $7.7 million, 34.89% up from the prior year.
  • Long-Term Deferred Tax for Q1 2018 was $9.8 million at Idexx Laboratories, up from $7.7 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $9.8 million in Q1 2018 and troughed at $5.7 million in Q4 2016.
  • A 3-year average of $7.3 million and a median of $7.2 million in 2017 define the central range for Long-Term Deferred Tax.
  • Biggest five-year swings in Long-Term Deferred Tax: surged 34.89% in 2017 and later skyrocketed 67.43% in 2018.
  • Year by year, Long-Term Deferred Tax stood at $5.7 million in 2016, then soared by 34.89% to $7.7 million in 2017, then rose by 27.6% to $9.8 million in 2018.
  • Business Quant data shows Long-Term Deferred Tax for IDXX at $9.8 million in Q1 2018, $7.7 million in Q4 2017, and $7.9 million in Q3 2017.